Results overview: Found 2 records in 0.02 seconds.
Articles, 2 records found
Articles 2 records found  
1.
13 p, 938.1 KB Cost-Effectiveness Analysis of Triple Therapy with Budesonide/ Glycopyrronium/ Formoterol Fumarate versus Dual Therapy in Patients with Chronic Obstructive Pulmonary Disease in Spain / Trigueros, Juan Antonio (Servicio de Salud de Castilla-La Mancha) ; Garin, Noe (Institut d'Investigació Biomèdica Sant Pau) ; Baloira, Adolfo (Hospital Universitario de Pontevedra) ; Aceituno, Susana (Outcomes'10) ; Calvo, Ana (Outcomes'10) ; Prades, Miriam (Outcomes'10) ; Touron, Carolina (AstraZeneca Farmacéutica España) ; Martínez, Anisia (AstraZeneca Farmacéutica España) ; Torres, Covadonga (AstraZeneca Farmacéutica España) ; Universitat Autònoma de Barcelona
To evaluate the cost-effectiveness of Budesonide/Glycopyrronium/Formoterol (BUD/GLY/FOR) versus LAMA/LABA and ICS/ LABA, respectively, in patients with moderate to severe COPD, from the Spanish National Healthcare System (NHS) perspective. [...]
2022 - 10.2147/COPD.S384591
International journal of COPD, Vol. 17 (2022) , p. 2905-2917  
2.
11 p, 594.6 KB A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease / Miravitlles, Marc (Hospital Universitari Vall d'Hebron) ; Cosio, Borja G.. (Institut d'Investigació Sanitària Illes Balears) ; Arnedillo, Aurelio (Universidad de Cádiz) ; Calle Rubio, Myriam (Universidad Complutense de Madrid) ; Alcázar-Navarrete, Bernardino (Hospital de Alta Resolución de Loja) ; González, Cruz (Hospital Clínic Universitari (València)) ; Esteban, Cristóbal (Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas) ; Trigueros, Juan Antonio (Centro de Salud Menasalbas) ; Rodríguez González-Moro, José Miguel (Hospital Universitario Príncipe de Asturias (Alcalá de Henares, Madrid)) ; Quintano Jiménez, José Antonio (Centro de Salud Lucena I, Lucena, Córdoba, Spain) ; Baloira, Adolfo (Complejo Hospitalario Universitario de Pontevedra) ; Universitat Autònoma de Barcelona
According to the current clinical practice guidelines for chronic obstructive pulmonary disease (COPD), the addition of inhaled corticosteroids (ICS) to long-acting β agonist therapy is recommended in patients with moderate-to-severe disease and an increased risk of exacerbations. [...]
2017 - 10.1186/s12931-017-0682-y
Respiratory Research, Vol. 18 (november 2017)  

See also: similar author names
1 Trigueros, J.A.
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.